Andersen Lars Louis, López-Bueno Rubén, Kandola Aaron, Núñez-Cortés Rodrigo, López-Bueno Laura, Calatayud Joaquín
National Research Centre for the Working Environment, Copenhagen, Denmark.
Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
Psychol Med. 2025 Feb 4;55:e2. doi: 10.1017/S003329172400343X.
Little is known about the dose and pattern of moderate-to-vigorous physical activity (MVPA) to prevent depression. We aimed to assess the prospective association of dose and pattern of accelerometer-derived MVPA with the risk of diagnosed depression.
We included 74,715 adults aged 40-69 years from the UK Biobank cohort who were free of severe disease at baseline and participated in accelerometer measurements (mean age 55.2 years [SD 7.8]; 58% women). MVPA at baseline was derived through 1-week wrist-worn accelerometry. Diagnosed depression was defined by hospitalization with ICD-10 codes F32.0-F32.A. Restricted cubic splines and Cox regression determined the prospective association of dose and pattern of MVPA with the risk of incident depression.
Over a median 7.9-year follow-up, there were 3,089 (4.1%) incident cases of depression. Higher doses of MVPA were curvilinearly associated with lower depression risk, with the largest minute-per-minute added benefits occurring between 5 (HR 0.99 [95% CI 0.96-0.99]) and 280 (HR 0.67 [95% CI 0.60-0.74]) minutes per week (reference: 0 MVPA minutes).
Regardless of pattern, higher doses of MVPA were associated with lower depression risk in a curvilinear manner, with the greatest incremental benefit per minute occurring during the first 4-5 h per week. Optimal benefits occurred around 15 h/week.
关于预防抑郁症的中等到剧烈身体活动(MVPA)的剂量和模式,人们了解甚少。我们旨在评估通过加速度计测量得出的MVPA剂量和模式与确诊抑郁症风险之间的前瞻性关联。
我们纳入了英国生物银行队列中74715名年龄在40至69岁之间的成年人,他们在基线时无严重疾病且参与了加速度计测量(平均年龄55.2岁[标准差7.8];58%为女性)。基线时的MVPA通过佩戴一周的手腕加速度计测量得出。确诊抑郁症定义为因ICD - 10编码F32.0 - F32.A住院治疗。受限立方样条和Cox回归确定了MVPA剂量和模式与新发抑郁症风险之间的前瞻性关联。
在中位7.9年的随访期间,有3089例(4.1%)新发抑郁症病例。较高剂量的MVPA与较低的抑郁症风险呈曲线相关,每分钟增加的最大益处出现在每周5(风险比0.99[95%置信区间0.96 - 0.99])至280(风险比0.67[95%置信区间0.60 - 0.74])分钟之间(参考:每周0分钟MVPA)。
无论模式如何,较高剂量的MVPA与较低的抑郁症风险呈曲线相关,每周前4至5小时每分钟的增量益处最大。最佳益处出现在每周约15小时。